Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacodynamic Study of Porcine Sodium Heparin (União Química) in Healthy Participants
NCT03113084Phase 1Suspended
- Sponsor
- União Química
- Start
- Aug 2022
- Primary completion
- Apr 2023
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of dextrose monohydrate + heparin sodium in venous thromboembolism (VTE) (2 arms), sponsored by União Química. Primary endpoint: Activity of the anti-Xa factor at 8 hours. Started Aug 2022; status: suspended.
02
Drugs
dextrose monohydrate + heparin sodium
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT03113084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03113084.